Advertisement

O04Prevalent but not inevitable: mapping contraception deserts across the american states

      This paper is only available as a PDF. To read, Please Download here.

      Objectives

      To provide a socio-spatial analysis of the allocation of Title X funding, the federal government's only program dedicated to reproductive healthcare; to systematically assess whether access to publicly-funded reproductive health resources are distributed in an equitable way across the US; to utilize an innovative measure of potential access that incorporates both spatial and aspatial variables to ascertain the size, scope, and demographic characteristics of geographies of concentrated disadvantage, which we refer to as “contraception deserts.”

      Methods

      We employed methods that incorporated geographic information systems (GIS) and statistical/spatial analysis. We used the integrated two-step floating catchment area (I2SFCA) method, which incorporates both spatial (eg, distance, rurality/urbanicity) and aspatial (eg, poverty) variables, to more accurately develop a measure of potential access to Title X–funded clinics (FY2019). To map contraception deserts and to determine the demographic profile of these spaces of inequity, we used US Census data (at the tract level) and Title X–clinic location data from the Office of Population Affairs.

      Results

      GIS mapping techniques illustrate that significant proportions of the US can be characterized as contraception deserts, though with a great deal of variability in size across them. However, historically marginalized racial groups and those experiencing poverty are disproportionately represented in contraception deserts.

      Conclusions

      Given the various ways Title X can be implemented across states, results reveal that contraception deserts are prevalent but not inevitable. Speaking to policy implication, the results show that with strategic siting decisions, state-level Title X networks can mitigate inequitable access to federal resources.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect